From previous announcements: a test and reader for hormone...

From previous announcements:

a test and reader for hormone monitoring (IVF test? Hologic?):
In August, Lumos announced it had received $270k in purchase orders for the manufacture of a unique,multi-assay, rapid diagnostic cartridge to be used in combination with a customized Lumos digital readerplatform as part of a novel hormone monitoring platform. The commencement of pilot manufacturing atthe Lumos Carlsbad Californian facility followed the completion of a $320k manufacturing validationprogram by Lumos and the product receiving CE-Mark certification. The hormone monitoring platformwill be used by IVF patients at-home and within the clinical environment as part of several clinical studiesto be conducted across Asia Pacific, Europe and the USA. The clinical studies will assess the impact of theuse of the hormone monitoring platform on clinical workflows and decision making. The studies are beingconducted as a pre-cursor to a potential market launch in FY2024

Supply of test strips for a nutrition test (Maybe Alden?):Alden is a technology company focused on making product, environmental, and process testing simple and informative for companies throughout the agriculture supply chain. Alden is a platform where members can conduct on-demand testing, access and share information, trace and track products, certify quality of products, and access other software features that keep you in compliance and maximize the quality of your product.

a new test for food safety testing (Food in Depth):The FoodID Antibiotic Residue Test consists of eight (8) immunoassays in a lateral flow format. Each assay utilizes visual labels attached to monoclonal detection antibodies in a competitive format to quantify the amount of target analyte present in a test specimen. The visual signal created by the assay is detected by a camera-based reader platform which compares the detected signal against a lot-specific factory calibration to produce a result. This method allows for the quantitative measurement of an analyte in a given specimen.

a novel molecular diagnostics platform (Apatek):
During the quarter, Lumos announced it had secured a development contract with New Jersey-basedAptatek Biosciences Inc., to develop a product to assist with screening and monitoring for phenylketonuria(PKU). The initial phase of this partnership is expected to generate at least $500,000 in revenue for Lumoswith further potential revenue from additional development activities and ongoing instrumentmanufacturing conducted in subsequent phases of the partnership. The majority of revenue from theinitial phase of this partnership is expected to be recorded during 1H FY2023.Aptatek is aiming to commence further studies and activities using the test developed by Lumos in Q1CY2023 with US commercial launch expected later in CY2023. Subject to regulatory approvals andexecution of a commercial contract manufacturing agreement, Aptatek intends to engage Lumos as theinstrument manufacturing partner for the product.

a pilot project focused on the development of a new animal health product:
Not sure what this one is about.


Services Expands Contract Manufacturing for Diabetomics:
Lumos continues to perform contract manufacturing for Diabetomics, which has noted increased demand for Diabetomics’ CovAb™ antibody test. Lumos has increased its monthly manufacturing volumes to support this growth. SARS-CoV-2 Antibody Test.

Macropak:
Mold testing? Not much update on this one i can see.

FFN (Hologic):
Focus on the development of next generation point of care technologies and intellectual property rights for custom reader. TLIIQ